Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Did the BPC-157 peptide get approved by the FDA in 2026
Documentation and handling reference GHK-CU: Documentation, Handling and Quality Record for This SKU The section above covers what GHK-CU is and what the published literature has looked at
Which peptides are being considered by the FDA
Participants: Over 1,200 patients
As of 2026, injectable GHK-Cu is classified as Category 2 by the FDA, restricting it from 503A compounding pharmacies
GHK-Cu is a small copper-binding tripeptide made of the amino acids glycine, L-histidine, and L-lysine (Gly-His-Lys) complexed with a copper(II) ion
US$ 28.44
US$ 28.58
US$ 29.79
US$ 21.41
US$ 29.71
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
